Craft

China Resources Pharmaceutical Group

Stock Price

$5.7

2024-10-29

Market Capitalization

$34.8 B

2024-10-29

Revenue

¥269.6 B

FY, 2025

China Resources Pharmaceutical Group Summary

Company Summary

Overview
China Resources Pharmaceutical Group (CR Pharma, 华润医药集团有限公司) is a company that specializes in the production and distribution of pharmaceuticals. It manufactures chemical drugs, Chinese medicines, and biopharmaceutical drugs as well as nutritional and healthcare products, covering a wide range of therapeutic areas including cardiovascular, alimentary tract and metabolism, large-volume IV infusion, pediatrics, respiratory system, etc.
Type
Public
Status
Active
Founded
2007
HQ
Hong Kong, HK | view all locations
Website
https://www.crpharm.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Hong Kong, Hong Kong Island HQ

    Hong Kong

    China Resources Building, 26 Harbour Rd, Wan Chai

China Resources Pharmaceutical Group Financials

Summary Financials

Revenue (FY, 2025)
¥269.6B
Gross profit (FY, 2025)
¥50.5B
Net income (FY, 2025)
¥9.7B
Cash (FY, 2025)
¥15.8B
EBIT (FY, 2025)
¥14.2B
Enterprise value
$113.1B

Footer menu